Cargando…
Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009–2010
Nitroimidazoles (metronidazole and tinidazole) are the only recommended drugs for treating Trichomonas vaginalis infection, and previous samples that assessed resistance of such isolates have been limited in geographic scope. We assessed the prevalence of in vitro aerobic metronidazole and tinidazol...
Autores principales: | Kirkcaldy, Robert D., Augostini, Peter, Asbel, Lenore E., Bernstein, Kyle T., Kerani, Roxanne P., Mettenbrink, Christie J., Pathela, Preeti, Schwebke, Jane R., Secor, W. Evan, Workowski, Kimberly A., Davis, Darlene, Braxton, Jim, Weinstock, Hillard S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358158/ https://www.ncbi.nlm.nih.gov/pubmed/22608054 http://dx.doi.org/10.3201/eid1806.111590 |
Ejemplares similares
-
In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure
por: Augostini, Peter, et al.
Publicado: (2023) -
Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea — STD Surveillance Network, United States, 2016
por: Weston, Emily J., et al.
Publicado: (2018) -
Identification of Trichomonas vaginalis 5-Nitroimidazole Resistance Targets
por: Graves, Keonte J., et al.
Publicado: (2023) -
Trichomonas vaginalis in Pregnancy
por: Faro, Sebastian
Publicado: (1994) -
Extragenital Gonorrhea and Chlamydia Testing Among Women Reporting Extragenital Exposure at an Urban STD Clinic: Is It Worth the Cost?
por: Caragol, Laura, et al.
Publicado: (2017)